Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese

52Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The recently discovered apolipoprotein A5 (APOA5) gene has been shown to be important in determining plasma triglyceride levels, a major cardiovascular disease risk factor. We searched for possible associations of the APOA5 gene polymorphisms S19W and -1131T>C with coronary heart disease (CHD) in a Chinese population. A total of 483 Chinese CHD patients and 502 control non-CHD subjects were genotyped by polymerase chain reaction-restriction fragment length polymorphism for these 2 single nucleotide polymorphisms. We found that the minor allele 19W was observed only in CHD patients and not in controls, with allelic frequencies of 0.047 and 0.000, respectively (P C variations in the APOA5 gene are associated with the CHD and appear to be 2 genetic risk factors for CHD susceptibility in Chinese. Moreover, we found that triglyceride levels were significantly higher in -1131C carriers than in -1131T subjects of the control group and that high-density-lipoprotein cholesterol was decreased in -1131C carriers among CHD patients. © 2005 Published by Elsevier Inc.

Cite

CITATION STYLE

APA

Liu, H., Zhang, S., Lin, J., Li, H., Huang, A., Xiao, C., … Huang, D. (2005). Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism: Clinical and Experimental, 54(5), 568–572. https://doi.org/10.1016/j.metabol.2004.11.009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free